Antonio D'Alessio

Imperial College London

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom Professors in Cancer Biology Cancer Biology professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (10)

Johann von Felden

University Medical Center Hamburg-Eppendorf

GERMANY

View details

Marco Gaetano Tucci

Assistant Professor

University of Bari

ITALY

View details

David J. Pinato

Imperial College London

UNITED KINGDOM

View details

Bruno Vincenzi

Professor of Medical Oncology

Università Campus Bio-Medico

ITALY

View details

Sebastiano Buti

ITALY

View details

Alessio Cortellini

Imperial College London

UNITED KINGDOM

View details

Melissa Bersanelli

Adjunct Professor in Medical Oncology

University of Parma

ITALY

View details

Nicola Personeni

Humanitas University

ITALY

View details

Lorenza Rimassa

Humanitas University

ITALY

View details

Robert Goldin

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Antonio D'Alessio

Research Interests

Explore related searches

Contact this professor

Articles (10)

Type 2 Diabetes Mellitus and Efficacy Outcomes from Immune Checkpoint Blockade in Patients with Cancer

Network meta-analysis: A map to navigate the maze of treatment for advanced hepatocellular carcinoma

Association between antibiotics and adverse oncological outcomes in patients receiving targeted or immune-based therapy for hepatocellular carcinoma

Determinants of Treatment Benefit and Post-Treatment Survival for Patients with Hepatocellular Carcinoma Enrolled in Second-Line Trials after the Failure of Sorafenib Treatment

Comparative efficacy of novel combination strategies for unresectable hepatocellular carcinoma: A network metanalysis of phase III trials

Preliminary evidence of safety and tolerability of atezolizumab plus bevacizumab in patients with hepatocellular carcinoma and Child‐Pugh A and B cirrhosis: A real‐world study

Tumour burden score and immune‐related hepatotoxicity in patients with hepatocellular carcinoma or liver metastases treated with immune checkpoint inhibitors

Cabozantinib plus atezolizumab for the treatment of advanced hepatocellular carcinoma: shedding light on the preclinical rationale and clinical trials

The dual checkpoint blockade in unresectable hepatocellular carcinoma: opportunities emerging in clinical trials

Predictive biomarkers of response to immune checkpoint inhibitors in hepatocellular carcinoma

Collaborators (10)

Johann von Felden

Marco Gaetano Tucci

David J. Pinato

Bruno Vincenzi

Sebastiano Buti

Alessio Cortellini

Melissa Bersanelli

Nicola Personeni

Lorenza Rimassa

Robert Goldin

Make your next move.